Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
Authors:
Open Access
- 25 April 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10
Abstract
Background: The goal of this study was to develop and validate a radiomics signature based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) preoperatively differentiating luminal and non-luminal molecular subtypes in patients with invasive breast cancer.Methods: One hundred and thirty-five invasive breast cancer patients with luminal (n = 78) and non-luminal (n = 57) molecular subtypes were divided into training set (n = 95) and testing set (n = 40) in a 7:3 ratio. Demographics and MRI radiological features were used to construct clinical risk factors. Radiomics signature was constructed by extracting radiomics features from the second phase of DCE-MRI images and radiomics score (rad-score) was calculated. Finally, the prediction performance was evaluated in terms of calibration, discrimination, and clinical usefulness.Results: Multivariate logistic regression analysis showed that no clinical risk factors were independent predictors of luminal and non-luminal molecular subtypes in invasive breast cancer patients. Meanwhile, the radiomics signature showed good discrimination in the training set (AUC, 0.86; 95% CI, 0.78–0.93) and the testing set (AUC, 0.80; 95% CI, 0.65–0.95).Conclusion: The DCE-MRI radiomics signature is a promising tool to discrimination luminal and non-luminal molecular subtypes in invasive breast cancer patients preoperatively and noninvasively.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 41 references indexed in Scilit:
- Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter StudyClinical Cancer Research, 2019
- Metabolic Reprogramming in Breast Cancer and Its Therapeutic ImplicationsCells, 2019
- A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular CarcinomaLiver Cancer, 2018
- Breast cancer prognosis signature: linking risk stratification to disease subtypesBriefings in Bioinformatics, 2018
- Spatiotemporal features of DCE-MRI for breast cancer diagnosisComputer Methods and Programs in Biomedicine, 2018
- Luminal A Breast Cancer and Molecular Assays: A ReviewThe Oncologist, 2018
- Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based studyThe Lancet Oncology, 2017
- Clinical implications of the intrinsic molecular subtypes of breast cancerThe Breast, 2015
- Can Breast MRI Predict Axillary Lymph Node Metastasis in Women Undergoing Neoadjuvant ChemotherapyAnnals of Surgical Oncology, 2010
- Magnetic resonance imaging for axillary staging in patients with breast cancerJournal of Magnetic Resonance Imaging, 2009